title: Diffuse Neonatal Hemangiomatosis: report of 5 cases.
abstract: Diffuse Neonatal Hemangiomatosis (DNH) is a rare, life-threatening condition associated with a few to hundreds of small, cutaneous and visceral hemangiomas. The authors reported 5 cases of DNH in which hepatic hemangioma were the most common visceral involvement. Response to prednisolone in these cases was not good, one died and four required second line therapy. Of these four cases, one case with embolisation; one with interferon and two with vinblastine. Response to vinblastine was good, but long-term follow-up of the side effects are needed.
authors.affiliation: Division of Pediatric Dermatology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. wananusw@hotmail.com
authors.forename: Siriwan
authors.initials: S
authors.lastname: Wananukul
authors.forename: Wanlapa
authors.initials: W
authors.lastname: Voramethkul
authors.forename: Issarang
authors.initials: I
authors.lastname: Nuchprayoon
authors.forename: Panya
authors.initials: P
authors.lastname: Seksarn
mesh_terms: D000798:Angiomatosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D005260:Female; D006391:Hemangioma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008113:Liver Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D014747:Vinblastine / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D011239:Prednisolone